Condition
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma clinical trials and research
Research outlook What's coming for Esophageal squamous cell carcinoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 3 Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma clinical trials that are recruiting, in China. By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 1Country
Newest Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Short-course definitive chemoradiotherapy with camrelizumab for locally advanced unresectable esophageal squamous cell carcinoma | Phase 2 | Nanjing, Jiangsu | Recruiting | Apr 15, 2026 |
| Intensive nutrition during conversion therapy to enable surgery for locally advanced unresectable esophageal squamous cell carcinoma | Phase 2 | Chengdu, Sichuan | Recruiting | Apr 9, 2026 |
| Oral paclitaxel combined with radiotherapy for locally advanced unresectable esophageal squamous cell carcinoma | Phase 2 | Nanjing, Jiangsu | Recruiting | Feb 27, 2026 |
All recruiting trials (3)
-
Short-course definitive chemoradiotherapy with camrelizumab for locally advanced unresectable esophageal squamous cell carcinoma
This trial sees if adding camrelizumab to short-course chemoradiotherapy—given either during treatment and continued afterwards or given only as maintenance afterwards—improves tumor response and survival for adults with locally advanced unresectable esophageal squamous cell carcinoma.
-
Intensive nutrition during conversion therapy to enable surgery for locally advanced unresectable esophageal squamous cell carcinoma
This will test whether giving intensive enteral nutrition alongside PD-1 inhibitor plus chemotherapy helps people with locally advanced unresectable esophageal squamous cell carcinoma achieve higher rates of complete tumor removal after conversion therapy.
-
Oral paclitaxel combined with radiotherapy for locally advanced unresectable esophageal squamous cell carcinoma
This trial will try taking oral paclitaxel together with radiotherapy to treat people with locally advanced, unresectable esophageal squamous cell carcinoma who are elderly or cannot tolerate intravenous chemotherapy.
Related topics
Quick answers
How many Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.